**Core Concept**
Fibrinolytic therapy is used to dissolve blood clots, but it has certain contraindications due to the risk of bleeding. The underlying principle is to identify conditions where the risk of fibrinolysis outweighs its benefits.

**Why the Correct Answer is Right**
The correct answer is not provided, however, absolute contraindications for fibrinolytic therapy typically include active bleeding, recent intracranial hemorrhage, and severe uncontrolled hypertension.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific details of option A, it's challenging to provide a precise explanation.
**Option B:** Similarly, without specifics, option B cannot be directly addressed.
**Option C:** And option C also lacks detail.
**Option D:** Option D is also unspecified.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that fibrinolytic therapy should be used cautiously, especially in patients with a high risk of bleeding.

**Correct Answer:** Not provided in the query.